Ophthalmic Lasers Market Report 2022: Increasing Initiatives to Control Visual Impairment Bolster Growth – Yahoo Finance

DUBLIN, Jan. 21, 2023 /PRNewswire/ — Research and Markets
The “Ophthalmic Lasers Market Research Report by Type, Product, Application, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to  ResearchAndMarkets.com’s offering.
The Global Ophthalmic Lasers Market size was estimated at USD 2,062.53 million in 2021, USD 2,168.96 million in 2022, and is projected to grow at a CAGR of 5.33% to reach USD 2,817.68 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Ophthalmic Lasers to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Photo Disruption Ophthalmic Lasers, Photocoagulating Ophthalmic Lasers, and SLT Ophthalmic Lasers.
Based on Product, the market was studied across Diode Lasers, Excimer Lasers, Femtosecond Lasers, and Nd: YAG Lasers.
Based on Application, the market was studied across Age-related Macular Degeneration (AMD)Treatment, Cataract Surgery, Diabetic Retinopathy, Glaucoma Surgery, and Refractive Error.
Based on End-User, the market was studied across Ambulatory Service Centers, Clinics, and Hospitals..
Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ophthalmic Lasers Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Market Dynamics
High Prevalence of Ophthalmic Disorders
Rising Prevalence of Chronic Diseases Such as Diabetes
Increasing Initiatives to Control Visual Impairment
High Cost of Equipment and Therapy
Technological Advancements in Glaucoma Management
Penetration of Internet of Things (IoT) in Ophthalmic Laser Care
Availability of Alternative Therapies
Unfavorable Reimbursements for Laser Eye Surgeries

The report answers questions such as:

1. What is the market size and forecast of the Global Ophthalmic Lasers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ophthalmic Lasers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ophthalmic Lasers Market?
4. What is the competitive strategic window for opportunities in the Global Ophthalmic Lasers Market?
5. What are the technology trends and regulatory frameworks in the Global Ophthalmic Lasers Market?
6. What is the market share of the leading vendors in the Global Ophthalmic Lasers Market?
7. What modes and strategic moves are considered suitable for entering the Global Ophthalmic Lasers Market?

Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Ophthalmic Lasers Market, by Type
7. Ophthalmic Lasers Market, by Product
8. Ophthalmic Lasers Market, by Application
9. Ophthalmic Lasers Market, by End-User
10. Americas Ophthalmic Lasers Market
11. Asia-Pacific Ophthalmic Lasers Market
12. Europe, Middle East & Africa Ophthalmic Lasers Market
13. Competitive Landscape
14. Company Usability Profiles
15. Appendix
Companies Mentioned
A.R.C. Laser
Abbott Medical Optics
Bausch & Lomb
Calmar Laser
Carl Zeiss Meditec
Ellex Medical Lasers
For more information about this report visit https://www.researchandmarkets.com/r/t73v32
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Laura Wood | +353-1-481-1716 | [email protected]
View original content:https://www.prnewswire.com/news-releases/ophthalmic-lasers-market-report-2022-increasing-initiatives-to-control-visual-impairment-bolster-growth-301726783.html
SOURCE Research and Markets
Today we will run through one way of estimating the intrinsic value of Axalta Coating Systems Ltd. ( NYSE:AXTA ) by…
Does the January share price for Simpson Manufacturing Co., Inc. ( NYSE:SSD ) reflect what it's really worth? Today, we…
Today we will run through one way of estimating the intrinsic value of Sigma Lithium Corporation ( NASDAQ:SGML ) by…
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see…
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it…
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is…
To get a sense of who is truly in control of OptimizeRx Corporation ( NASDAQ:OPRX ), it is important to understand the…
Profit from folly. Don’t participate in it.
The S&P 500 dipped by 19% in 2022, but stocks still don’t seem cheap to Charlie Munger, Warren Buffett’s billionaire partner at Berkshire Hathaway. “In my whole adult life, I have never hoarded cash, waiting for better conditions,” Munger said in an interview in late 2022. “I’ve just invested in the best thing I could find.” Yet he acknowledged that Berkshire Hathaway is sitting on billions of dollars in cash. The reason isn’t that Buffett and Munger think they can wait for stocks to get even ch
It's not a bad idea to check what stocks Warren Buffett's Berkshire Hathaway owns. A $1,000 investment in the company in 1965, when he took over, would have been worth $36 million through 2021. Keep in mind that many of Berkshire's stocks were not selected by Buffett, but were chosen by one of his investing lieutenants, Ted Weschler and Todd Combs, who have also have an impressive investing record.
Despite what looks to be increasingly conservative top-line expectations, both names have retrenched in recent weeks.
The boom in special purpose acquisition companies (SPACs) and flurry of initial public offerings (IPOs) in 2020 and 2021 produced a lot of public companies that are starting to run into serious financial trouble in this difficult economic environment. Banking disruptor SoFi Technologies (NASDAQ: SOFI) was a product of the SPAC boom, and like many of its fellow ex-SPACs, its stock has performed poorly — down about 79% from the peak. In addition to the general cooling off of high-growth stocks, investors are frustrated that SoFi's core student loan refinancing business remains at a virtual standstill, and there are worries that higher interest rates could hurt its lending operations, by far the more profitable side of the business.
Our call of the day from TheoTrade's Professor Jeff Bierman warns that the next group of stocks to come under pressure will be consumer staples.
Finding young and growing tech stocks is crucial to any investor's portfolio. The explosive returns these investments can have on a portfolio can accelerate your financial goals faster than nearly any other investment — if purchased for the right price. Unfortunately, many investors found themselves on the wrong side of this coin during 2021, as many growth names were unrealistically valued.
Many Americans are surprised to see they have not prepared as well as they had hoped for retirement when they finally get ready to call it quits. The bad news is, you’ll probably have to make some realistic assumptions of what your retirement will look like. If you’ve lived primarily paycheck to paycheck in your working years, that may continue to feel the case in your retirement.
After two decades of staying privately held, big-data analytics company Palantir Technologies (NYSE: PLTR) went public in Sept. 2020. While the company boasts several U.S. government agencies as well as brand-name commercial sector companies on its client roster, Wall Street has expressed concerns about Palantir's near-term growth rate. Palantir is off to a great start in 2023, and although some of the analyst concerns are valid, its valuation looks appealing for long-term investors.
Finding the right stock is the key to successful investing, but it’s never as easy as it sounds. The answer to the question, which stock to buy? is no secret, but it is hidden, in the avalanche of data that the markets produce. What’s needed is some clear signal that will cut through the noise and indicate the right stocks for the times. The quantity of data, and the sheer impossibility of parsing all of it in real time, makes a formidable barrier to successful stock picking – but Wall Street’s
No company is certain to avoid significant cutbacks in an economic environment as volatile as the current one, and Apple isn’t immune to the business challenges that have hit other tech giants. It is expected next month to report its first quarterly sales decline in more than three years. Apple has also slowed hiring in some areas.
You won’t even owe him a penny for his thoughts.
The e-commerce veteran split its stock in 2022 after a 23-year moratorium. That action speaks volumes.


Leave a Reply

Your email address will not be published.